02Jun 2023
Clinical outcomes associated with drugs for obesity and overweight: A systematic review and network meta‐analysis of randomized controlled trials

Clinical outcomes associated with drugs for obesity and overweight: A systematic review and network meta‐analysis of randomized controlled trials

This systematic review compared the benefits and harms of drugs approved for weight management in adults with obesity or overweight. The results showed no significant differences in the associations between these drugs and cardiovascular death. However, naltrexone/bupropion was associated with lower cardiovascular mortality than placebo. All drugs resulted in greater weight loss and waist circumference reduction at 12 months compared to the placebo, with semaglutide and phentermine/topiramate showing the most significant effects. Semaglutide and phentermine/topiramate also had lower or no difference in the odds of treatment withdrawal compared to other drugs.

  • #endo-diabetology

Like

Save

Share